A man in his 20s developed adult-onset reversible idiopathic hypogonadotropic hypogonadism after fathering his first child, carrying a heterozygous missense variant in WDR11 (c.2390G>A; p.Arg797His), and achieved sustained improvement after 4 years of gonadotropin-releasing hormone replacement therapy that was then discontinued.
Key Findings
Background
The patient developed adult-onset IHH after having his first child, presenting initially with gynecomastia.
The patient was a man in his 20s who had already fathered one child prior to diagnosis.
Initial presentation was gynecomastia, which led to the subsequent diagnosis of IHH.
This represents an unusual adult-onset presentation, as IHH occurs mostly in childhood or adolescence and very rarely in adulthood.
The case is notable because adult-onset IHH is characterized by delayed onset of secondary sexual characteristics in typical congenital cases, but this patient had prior normal reproductive function.
Results
The patient carried a heterozygous missense variant in WDR11 (c.2390G>A; p.Arg797His) that may have contributed to adult-onset IHH and its reversal.
The variant identified was a heterozygous missense mutation: c.2390G>A; p.Arg797His in the WDR11 gene.
Many genetic abnormalities have been reported in congenital IHH cases, but genetic findings are rarely reported in adult-onset IHH cases.
The authors suggest this WDR11 variant 'may play a role in adult-onset IHH reversal.'
WDR11 mutations have been previously associated with IHH, and this case adds to understanding of the genetic component of the condition.
Results
The patient's IHH was reversible; he responded to gonadotropin-releasing hormone replacement therapy, fathered two additional children, and sustained improvement after treatment discontinuation.
The patient was treated with gonadotropin-releasing hormone replacement therapy.
During treatment, he fathered two more children (for a total of three children).
Treatment was discontinued after 4 years.
Improvement was sustained after treatment discontinuation, consistent with the reversibility of IHH.
The authors note that 'IHH requires lifelong hormone replacement therapy; however, a few reports suggest the reversibility of this condition,' placing this case among rare reversible IHH cases.
Conclusions
Accumulation of adult-onset reversible IHH cases with identified genetic variants may contribute to understanding of IHH pathogenesis.
The authors state that 'accumulation of such cases can contribute to our understanding of the pathogenesis and genetic component of IHH.'
Genetic abnormalities have been rarely reported specifically in adult-onset IHH cases.
The identification of a WDR11 missense variant in this reversible adult-onset case highlights the potential genetic underpinnings of atypical IHH presentations.
Yamada R, Yamakita N, Yasuda K, Imai A. (2022). Adult-onset reversible idiopathic hypogonadotropic hypogonadism in male adult carrying a WDR11 missense mutation.. BMJ case reports. https://doi.org/10.1136/bcr-2022-250444